{
"item_title" : "Targeting Oncogenic Driver Mutations in Lung Cancer",
"item_author" : [" Matthew Lee", "Fawzi Abu Rous", "Alain Borczuk "],
"item_description" : "The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.",
"item_img_path" : "https://covers3.booksamillion.com/covers/bam/1/00/933/613/1009336134_b.jpg",
"price_data" : {
"retail_price" : "25.00", "online_price" : "25.00", "our_price" : "25.00", "club_price" : "25.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : ""
}
}
Targeting Oncogenic Driver Mutations in Lung Cancer
Overview
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
This item is Non-Returnable
Customers Also Bought
Details
- ISBN-13: 9781009336130
- ISBN-10: 1009336134
- Publisher: Cambridge University Press
- Publish Date: February 2023
- Dimensions: 9 x 6 x 0.2 inches
- Shipping Weight: 0.31 pounds
- Page Count: 96
Related Categories
